Dubin Glenn

CIK 00013085977 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001308597

Recent Transactions

50 trades

Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-04-01$8.10/sh+1,358→ 22,075 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2024-01-02$6.52/sh+1,687→ 20,717 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-10-02$1.70/sh+6,470→ 19,030 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-07-03$2.83/sh+3,887→ 12,560 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2023-06-15+26,000→ 26,000 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-04-03$3.20/sh+3,438→ 8,673 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2023-01-03$6.38/sh+1,725→ 5,235 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-10-03$8.69/sh+1,265→ 3,510 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-07-01$8.03/sh+1,372→ 2,245 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2022-06-22+23,500→ 23,500 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-04-04$26.46/sh+379→ 873 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2022-01-04$31.58/sh+199→ 494 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-10-04$44.99/sh+138→ 295 total
Award
C4 Therapeutics, Inc.$CCCC
Common Stock
2021-07-02$39.72/sh+157→ 157 total
Award
C4 Therapeutics, Inc.$CCCC
Stock Option (Right to Buy)
2021-03-12+41,200→ 41,200 total
Sale
Corbin Multi-Strategy Fund, LLC
Class I Units
2012-06-30$102.67/sh−20,785→ 0 total
Sale
Corbin Multi-Strategy Fund, LLC
Class I Units
2012-03-30$101.18/sh−24,542→ 20,428 total
Sale
Corbin Multi-Strategy Fund, LLC
Class I Units
2011-12-31$99.63/sh−63,585→ 44,766 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2011-03-31$2.99/sh−379,887→ 0 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2011-01-18$1.40/sh−15,600→ 379,887 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock
2011-01-14$1.41/sh+31,700→ 395,487 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2011-01-13$1.37/sh−38,079→ 427,187 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-07-29$0.48/sh−30,000→ 3,722,131 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-07-12$0.47/sh−15,800→ 3,752,131 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock, $.0.01 par value ("Common Stock")
2010-06-24$0.49/sh−18,000→ 3,767,931 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock
2010-06-23$0.48/sh−16,400→ 3,785,931 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock
2010-06-22$0.50/sh−18,302→ 3,802,331 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-06-21$0.51/sh−35,700→ 3,820,633 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value
2010-06-10$0.51/sh−2,498→ 3,856,333 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-06-03$0.49/sh−36,260→ 3,858,831 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-06-01$0.50/sh−23,000→ 3,895,091 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock
2010-05-28$0.50/sh−57,000→ 3,918,091 total
Sale
AMBASSADORS INTERNATIONAL INC
Common Stock
2010-05-27$0.51/sh−9,000→ 3,975,091 total
Sale
AMBASSADORS INTERNATIONAL INC
Common stock, $0.01 par value ("Common Stock")
2010-05-26$0.51/sh−47,498→ 3,984,091 total
Sale
Golden Minerals Co$AUMN
Common stock, $0.01 par value ("Common Stock")
2010-03-19$8.50/sh−347,766→ 45,075 total
Other
Golden Minerals Co$AUMN
Common stock, $0.01 par value ("Common Stock")
2009-03-24+1,604→ 392,841 total
Conversion
Euthymics Bioscience, Inc.
Common stock, $0.0001 par value per share ("Common Stock")
2007-06-11+13,295,418→ 13,295,418 total
Conversion
Euthymics Bioscience, Inc.
Series C Convertible Preferred Stock
2007-06-11−13,295,418→ 0 total
Other
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.20/sh−852→ 700 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.20/sh+852→ 1,552 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.26/sh+30,000→ 111,552 total
Other
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.19/sh−700→ 0 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.23/sh+40,000→ 41,552 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Shares of common stock, $0.01 par value ("Common Stock")
2007-03-02$8.19/sh+700→ 700 total
Other
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.26/sh−30,000→ 81,552 total
Other
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-03-02$8.25/sh−40,000→ 41,552 total
Other
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-02-15$8.71/sh−4,034→ 64,876 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-02-15$8.71/sh+4,034→ 68,910 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Shares of common stock, $0.01 par value ("Common Stock")
2007-02-15$8.67/sh+30,000→ 30,000 total
Purchase
ENZON PHARMACEUTICALS, INC.$ENZN
Common Stock
2007-02-15$8.72/sh+8,700→ 64,876 total

Companies

Address

C/O HIGHBRIDGE CAPITAL MANAGEMENT, LLC 9 WEST 57TH STREET, 27TH FLOOR

NEW YORK, NY, 10019

View on SEC.gov

Dubin Glenn

Recent Transactions

Companies

Recent Filings

Address